Drawing for ACULEUS THERAPEUTICS

USPTO serial 79325000

ACULEUS THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 6897658Status 700Registered
Filing date
Status date
Registration date
Nov 15, 2022
Examiner
KEAN, AMY C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACULEUS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Neil B Friedman

Neil B Friedman Hodgson Russ LLP605 Third Avenue, Suite 2300New York, NY 10158UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific research and development; Pharmaceutical research and development; Pharmaceutical research advisory and pharmaceutical testing services; Preparation of scientific reports; Scientific research, design, analysis and testing of pharmaceutical products; Conducting medical research; Conducting clinical trials for others in the field of pharmaceuticals; Provision of scientific information in the field of pharmaceutical products; Scientific and technical analysis in the field of medical and scientific research and pharmaceutical product research; Scientific research consultancy in the field of pharmaceuticals; Scientific research in the field of pharmacy; Medical research; research and development of products; Research relating to pharmaceuticals; Advisory and consultancy services relating to the aforementioned servicesACTIVE—
045Licensing of intellectual property rights; Legal services relating to the exploitation of patent and copyright intellectual property rights; Enforcement of intellectual property rights; Advisory services relating to intellectual property rights; Research relating to intellectual propertyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 5, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 13, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 12, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 15, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 15, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 10, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 22, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 22, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 30, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 30, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 16, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance